0000899243-23-020116.txt : 20231102 0000899243-23-020116.hdr.sgml : 20231102 20231102205307 ACCESSION NUMBER: 0000899243-23-020116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231031 FILED AS OF DATE: 20231102 DATE AS OF CHANGE: 20231102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Musso Alan A CENTRAL INDEX KEY: 0001295830 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 231374209 MAIL ADDRESS: STREET 1: FULCRUM THERAPEUTICS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 738 MAIN STREET STREET 2: UNIT 398 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 738 MAIN STREET STREET 2: UNIT 398 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-31 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001295830 Musso Alan A C/O AILERON THERAPEUTICS, INC 738 MAIN STREET #398 WALTHAM MA 02451 1 0 0 0 0 Stock Option (right to buy) 1.17 2023-10-31 4 A 0 5450 0.00 A 2033-10-30 Common Stock 5450 5450 D This option was granted on October 31, 2023. The shares underlying the option are scheduled to vest over 48 equal monthly installments from October 31, 2023, subject to continued service. /s/ Manuel C. Alves-Aivado, M.D., Ph.D., as attorney-in-fact for Alan Musso 2023-11-02